BTIG Maintains Buy on DexCom, Raises Price Target to $96
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
BTIG analyst Ryan Zimmerman maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $96.
BTIG analyst Ryan Zimmerman maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $96.